FDA authorizes software that can help identify prostate cancer
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
FDA advances data, IT modernization efforts with new office of digital transformation
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
ECDC and EMA highlight considerations for additional and booster doses of COVID-19 vaccines
- Details
- Category: EMA
![EMA EMA](/images/logo/ema.png)
FDA approves first COVID-19 vaccine
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
FDA approves new treatment for Pompe disease
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
Patients with Pompe disease have an enzyme deficiency that leads to the accumulation of a complex sugar, called glycogen, in skeletal and heart muscles, which cause muscle weakness and premature death from respiratory or heart failure.
FDA approves first interchangeable biosimilar insulin product for treatment of diabetes
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
FDA approves first oral blood thinning medication for children
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
More Pharma News ...
- FDA grants accelerated approval for Alzheimer's drug
- FDA approves new drug treatment for chronic weight management, first since 2014
- FDA authorizes additional monoclonal antibody for treatment of COVID-19
- FDA authorizes Pfizer-BioNTech COVID-19 vaccine for emergency use in adolescents in another important action in fight against pandemic
- FDA and CDC lift recommended pause on Johnson & Johnson (Janssen) COVID-19 vaccine use following thorough safety review
- FDA revokes emergency use authorization for monoclonal antibody Bamlanivimab
- Joint CDC and FDA statement on Johnson & Johnson COVID-19 vaccine